The Michaelis–Menten curves we reconstructed based on the findings in individual studies showed that overall, there was no substantial increase of SERT occupancy with SSRI and SNRI doses above the usual minimum recommended doses for depression. The gene discussed is SLC6A4; the disease is depressive symptom measurement.